Product information and disease descriptionProduct descriptionProduct information
Special populations
1 evidence topic · 1 source
United Kingdom 1.5 mg labeling: populations without recommended use
| Population | Quoted recommendation |
|---|---|
| Renal or hepatic impairment; adults older than 65 years; persons younger than 18 years | “not recommended” |